Hepatitis C virus is one of the main causes of chronic hepatitis in developing countries. There are 170 million affected people around the world as reported by the World Health Organization. 
Introduction
Hepatitis C virus (HCV) is an important human pathogen that causes acute and chronic hepatitis, cirrhosis and hepatocellular carcinoma worldwide. This positive stranded RNA virus is extremely efficient in establishing persistent infection by escaping immune detection or hindering the host immune responses 1 . HCV infection is a major cause of acute hepatitis and chronic liver disease. HCV was first There may also be ethnic and racial differences in the effects of HIV on immunoglobulin production 3, 4 .
The aim of this study was to evaluate Serum Protein Electrophoresis (SPE) as a marker for diagnosis of Hepatitis C and human immunodeficiency viruses diseases
Materials and method

Sample selection
The serum samples were obtained from As -Salam International Hospital, Maadi, Cairo. The HCV and HIV patients obeyed complete blood analysis according to specific criteria to be sure that these patients suitable for this experimental study.
Preparation of the sample for electrophoresis
The total protein concentration measured in the sample 5 . The sample mixed with the sample buffer with different percentages depending on concentration of the total protein in each sample. The protein concentration in each well must be in the range between 60 -80 μg proteins. 
Protein electrophoresis
Resolving gel (8%)
Gel solutions were prepared by mixing 14.4 ml distilled water, 8.1 ml of Acrylamide/Bis (30% T, 2.67% C) stock solution, and 7.5 ml Tris 
Running conditions
The electrode buffer was freshly prepared by dissolving 2.41 g of Tris base and 11.52 g of glycine in 800 ml of distilled water then the volume was completed to 1 L with distilled water. Electric current of 50 mA was applied on protein samples under cooling conditions at 4o C till the reach board line to end of the gel.
Staining
0.04% Coomassie brilliant blue G-250 in 3.5% perchloric acid staining solution was prepared using distilled water as solvent.
At the end of the run, electrical current was stopped and gels were removed from the plate assembly. Each gel was recovered into three times its volume of the staining solution that was placed in a suitable plastic container. The gels were stained overnight through the shaker then photographed after destining.
Data analysis
Gel plate was photographed, scanned and then analyzed using a gel pro Analyzer (Version 3. 
Results
The data compiled in table 1 The two control samples were compared to each other to show that there was no any unknown factor affecting the protein fractionation.
The similarity index between two samples was 1 and the genetic distance was 0.
The value 1 indicates the complete similarity between the two samples, while the value zero exhibits complete difference between the two samples. The genetic distance is inversely relationship with the similarity index. When the similarity index equals 1, the genetic distance equals 0. 
Discussions
At least 10 proteins including four structural proteins (core protein, two envelope proteins, E1, E2, and p7 ion channel) are the generated with the large HCV polyprotein which is cleared by the host and viral proteases. The six non-structural proteins include NS2-NS3-NS4A-NS4B-NS5A-NS5B-COOH cell to another, its main function is to form the capsid shell that houses and protects the HCV genomic RNA 13 . This study is biased because only patients who had indications for both SPEP and HIV tests were included. However, the patients with no indications for both SPEP and HIV tests are less prevalent to multiple myeloma and SPEP abnormalities.
Conclusion
In HIV-positive patients, monoclonal bands are not significantly increased and therefore valid despite this bias 15 .
Immunoglobulin levels are variables depending on differing risk behaviours 3 . Up till now there is controversy association regarding between HIV infection and multiple myeloma. There are some documented that increased risk (approximately 4.5-fold) of multiple myeloma in HIV/AIDS patients 16, 17 , while other aren't have 18 .
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